GRNA — Greenlight Biosciences Holdings PBC Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $45.43m
- $37.72m
- $6.78m
Brief: Greenlight Biosciences Holdings, PBC (GRNA) Enters Into Multitarget Licensing Agreement With Serum Institute Of India To Develop And Commercialize Messenger RNA Products For Emerging Markets Globally
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM
Brief: Environmental Impact Acquisition Corp Says Greenlight Biosciences Set To Begin Trading Under Nasdaq: GRNA On February 3, 2022
Brief: Greenlight Biosciences And Germains Seed Technology Partner To Explore Development Of World's First Dsrna Seed Treatment To Control Pests
Brief: ENVI Announces Quorum To Pass Business Combination With Greenlight
Brief: Environmental Impact Acquisition - Entered Into Letter Agreements, Dated Dec 29, 2021 With Greenlight Biosciences & Some Prepaying Investors
Brief: GreenLight (ENVI) And IAVI Begin Work On Omicron Variant-Adapted COVID-19 Vaccine Candidate
Brief: GreenLight Biosciences - Announced An Expansion Of Its Pipe Financing To An Aggregate $124 Mln In Gross Proceeds
U.S. STOCKS ON THE MOVE-Katapult, PharmaCyte Biotech, Fulcrum Therapeutics
U.S. STOCKS ON THE MOVE-Fulcrum Therapeutics, Lighting eMotors
Brief: Greenlight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp To Become Publicly Traded Company
Brief: RNA Tech Firm Greenlight Biosciences To Go Public In $1.5 Bln SPAC Deal- WSJ
Brief: Ericsson announces agreement to acquire Envivio Inc,
Brief: Ericsson set to buy U.S. video encoding firm Envivio for 125 mln USD
Brief: Envivio shareholders lawsuit concluded
Brief: Envivio Q1 non-GAAP loss per share $0.02
Brief: Envivio Q1 non-GAAP loss per share $0.02
Brief: Envivio Q4 non-GAAP loss per share $0.02
Brief: Cannell Capital says Envivio shares were undervalued